Chemoinformaics analysis of Ethyl trans-2-hexenoate
| Molecular Weight | 142.198 | nRot | 4 |
| Heavy Atom Molecular Weight | 128.086 | nRig | 1 |
| Exact Molecular Weight | 142.099 | nRing | 0 |
| Solubility: LogS | -3.168 | nHRing | 0 |
| Solubility: LogP | 3.775 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 24 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 10 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 8 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 24.2991 |
| nHD | 0 | BPOL | 16.6489 |
| QED | 0.436 |
| Synth | 1.659 |
| Natural Product Likeliness | 0.622 |
| NR-PPAR-gamma | 0.005 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.011 |
| Pgp-sub | 0.003 |
| HIA | 0.002 |
| CACO-2 | -4.442 |
| MDCK | 0.0000275 |
| BBB | 0.986 |
| PPB | 0.821056 |
| VDSS | 1.029 |
| FU | 0.267809 |
| CYP1A2-inh | 0.98 |
| CYP1A2-sub | 0.395 |
| CYP2c19-inh | 0.674 |
| CYP2c19-sub | 0.289 |
| CYP2c9-inh | 0.39 |
| CYP2c9-sub | 0.587 |
| CYP2d6-inh | 0.06 |
| CYP2d6-sub | 0.108 |
| CYP3a4-inh | 0.083 |
| CYP3a4-sub | 0.166 |
| CL | 4.657 |
| T12 | 0.571 |
| hERG | 0.077 |
| Ames | 0.008 |
| ROA | 0.032 |
| SkinSen | 0.909 |
| Carcinogencity | 0.186 |
| EI | 0.99 |
| Respiratory | 0.258 |
| NR-Aromatase | 0.012 |
| Antiviral | No |
| Prediction | 0.951314 |